Skip to main content
Methodology published · Market data, model notes, and corrections process are public · Data policy · Corrections policy
AMGN logo

NASDAQ · HEALTHCARE · Earnings & dividends

Amgen Inc earnings and payout view.

Next scheduled report in 64 days, last quarterly EPS, consensus estimates, payout status, and capital-return context for AMGN.

Next report
August 4, 2026
64 days · time TBD
EPS (TTM)
$14.38
Latest reported EPS
$5.15
Consensus: $4.77
Last EPS surprise
+8.0%
Beat · $5.15 actual vs $4.77 est.
EPS History & Surprise
PeriodActual EPSEst. EPSSurprise
Q1$0.13$0.13+0.0%
Q2$0.16$0.15+6.7%
Q3$0.16$0.15+6.7%
Q4$0.16$0.16+0.0%
Q1$0.16$0.16+0.0%
Q2$0.18$0.18+0.0%
Q3$0.17$0.17+0.0%
Q4$0.17$0.17+0.0%

Most recent periods shown. Full history available via data providers.

Dividends and capital return

Payout status beside the earnings base.

Dividend yield only makes sense next to earnings power. TECHi keeps payout ratio, yield, and ex-date on this page so income investors can read the cash return against EPS.

Forward yield
2.87%
Annual payout
$9.80 per share
Payout ratio
68% of EPS
Within historical norms
Ex-dividend date
May 15, 2026
Hold by this date for the next payout

EPS beat history

AMGN has 5 beats in the last 6 reported quarters.

Recent reported quarters are compared against the consensus estimate so the latest print is easy to read at a glance. Positive bars mean reported EPS cleared expectations; negative bars mark misses.

Last actual EPS
$5.15
Q1 FY2026
Last estimate
$4.77
April 30, 2026
Surprise amount
+$0.38

Recent quarters

Q1 FY2026+8.0%

$5.15 actual vs $4.77 est.

Q4 FY2025+11.8%

$5.29 actual vs $4.73 est.

Q3 FY2025+12.6%

$5.64 actual vs $5.01 est.

Q2 FY2025-15.1%

$2.65 actual vs $3.12 est.

Q1 FY2025+15.0%

$4.90 actual vs $4.26 est.

Q4 FY2024+4.5%

$5.31 actual vs $5.08 est.

Earnings call transcript

AMGN 2026Q1 call commentary.

12 segments

Operator

Operator

0.00

My name is Julianne, and I will be your conference facilitator today for the Amgen Inc. Q1 2026 Earnings Conference Call. All lines have been placed on mute to prevent any background noise. There will be a question and answer session at the conclusion of the...

Casey Capparelli

Vice President, Investor Relations

0.00

Thank you, Julianne. Good afternoon, everyone, and welcome to our 2026 earnings call. Robert A. Bradway will lead the call today and be followed by a broader review of our performance by Murdo Gordon, James E. Bradner, and Peter H. Griffith. Through the course...

Robert A. Bradway

Chairman and CEO

0.80

Good afternoon, and thank you for joining us. We had a strong first quarter and are well positioned to achieve our objectives for the year. Recall, we previously described 2026 as a springboard year for Amgen Inc., a year in which we expect our rapidly growing...

Murdo Gordon

Executive Vice President, Worldwide Commercial

0.70

Thanks, Bob. As mentioned, in 2026, 16 products achieved double-digit or better sales growth and 17 products are now annualizing at sales of $1 billion or more. Overall, we delivered 4% growth in product sales driven by a diversified portfolio of fast-growing...

James E. Bradner

President, Research & Development and Head of AI & Data Initiatives

0.80

Thank you, Murdo, and good afternoon, everyone. Let me begin with Meritide, a new paradigm in the management of obesity, obesity-related conditions, and type 2 diabetes. The unique antibody-peptide conjugate design of Meritide delivers a potential for strong...

Peter H. Griffith

Executive Vice President & Chief Financial Officer

0.60

Thank you, Jay. We are pleased with our strong first quarter performance, executing through a full quarter of the patent expirations and losses of exclusivity. Our non-GAAP operating margin was 45%. We continue to invest in advancing our pipeline with non-GAAP...

Earnings desk view

AMGN EPS history is live.

Amgen Inc has per-quarter EPS history available across recent reports, pairing the latest actual EPS with consensus estimates and valuation context. For real-time commentary on AMGN's next print, the news archive tracks every editorial reaction to earnings reports.

Payout history

AMGN dividend payments - recent history

Market data feed

Ex-dateAmountRecord datePayment date
$2.52
$2.52
$2.38
$2.38
$2.38
$2.38
$2.25
$2.25
$2.25
$2.25
$2.13
$2.13
$2.13
$2.13
$1.94
$1.94
$1.94
$1.94
$1.76
$1.76
$1.76
$1.76
$1.60
$1.60

Dividend safety read

AMGN pays out 68% of TTM earnings as dividends.

A payout ratio in this band gives the dividend room to grow even if earnings dip. Watch quarterly cash-flow coverage to confirm the buffer holds.

Frequently asked

Common questions.

When does AMGN next report earnings?

Amgen Inc reports quarterly. Track the latest scheduled date and consensus estimate on TECHi's AMGN earnings page — updated whenever the company confirms the quarterly call.

What is AMGN's EPS?

Amgen Inc's trailing earnings per share is approximately $14.38 based on the most recent fundamentals snapshot.

Where can I find AMGN's earnings history?

TECHi's AMGN earnings page covers the next scheduled report, the last several quarters of beats and misses, and editorial commentary tied to each release.

Did AMGN beat earnings last quarter?

Beat / miss commentary for the most recent Amgen Inc quarter is published on the TECHi AMGN earnings page. Subscribe to the markets newsletter for the morning brief on every print.

Does AMGN pay a dividend?

Yes — Amgen Inc (AMGN) pays a dividend with a current yield of approximately 2.87%.

What is AMGN's dividend yield?

Amgen Inc has a forward dividend yield of approximately 2.87% based on the most recent quote.

How much does AMGN pay in dividends per share?

Amgen Inc distributes approximately $9.80 per share annually based on the latest declared payout.

What is AMGN's payout ratio?

Amgen Inc's payout ratio is approximately 68.15%, the share of earnings paid out as dividends. A lower ratio leaves more room for dividend growth.

Where can I track AMGN's dividend history?

TECHi's AMGN earnings and dividends page shows the live yield, payout history, ex-dividend dates, payout ratio, and dividend-safety commentary beside EPS history.

Market data is provided for informational purposes only, refreshes through configured feeds when available, and is not intended for trading purposes. Prices and fundamentals can be delayed, cached, incomplete, or revised by upstream providers. Read the data methodology or the full disclaimer.